[
  {
    "ts": "2025-09-02T07:28:58+00:00",
    "headline": "Gilead Sciences, Inc. (GILD) Wins FDA Approval for World’s First Twice-Yearly HIV Preventive Therapy",
    "summary": "We recently compiled a list of the 10 High Growth Pharma Stocks That Are Profitable in 2025. Gilead Sciences, Inc. is placed seventh among them. Gilead Sciences, Inc. (NASDAQ:GILD) is making headlines with a breakthrough in HIV prevention following the FDA approval of Yeztugo, the world’s first twice-yearly preventive treatment. This milestone not only strengthens […]",
    "url": "https://finance.yahoo.com/news/gilead-sciences-inc-gild-wins-072858678.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "b51551ad-f03b-3d52-8f6a-b623d17e2d31",
      "content": {
        "id": "b51551ad-f03b-3d52-8f6a-b623d17e2d31",
        "contentType": "STORY",
        "title": "Gilead Sciences, Inc. (GILD) Wins FDA Approval for World’s First Twice-Yearly HIV Preventive Therapy",
        "description": "",
        "summary": "We recently compiled a list of the 10 High Growth Pharma Stocks That Are Profitable in 2025. Gilead Sciences, Inc. is placed seventh among them. Gilead Sciences, Inc. (NASDAQ:GILD) is making headlines with a breakthrough in HIV prevention following the FDA approval of Yeztugo, the world’s first twice-yearly preventive treatment. This milestone not only strengthens […]",
        "pubDate": "2025-09-02T07:28:58Z",
        "displayTime": "2025-09-02T07:28:58Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/8961adb4220c8e19ad4f57e8d4a062e4",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Gilead Sciences, Inc. (GILD) Wins FDA Approval for World’s First Twice-Yearly HIV Preventive Therapy",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/gJTDH1IHh_n1F0Y9hU39pQ--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/8961adb4220c8e19ad4f57e8d4a062e4.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/CRy7HYblsTY1bKtUAwhAPA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/8961adb4220c8e19ad4f57e8d4a062e4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/gilead-sciences-inc-gild-wins-072858678.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/gilead-sciences-inc-gild-wins-072858678.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]